Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc. has filed its quarterly report for the period ending September 30, 2025, indicating compliance with the Securities Exchange Act of 1934. The report highlights the company’s financial performance and operational updates, providing stakeholders with insights into its market positioning and strategic initiatives. The filing confirms ResMed’s status as a large accelerated filer, reflecting its significant market presence and operational scale.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$51.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, specializing in the development and manufacturing of medical devices and cloud-connected solutions for people with sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases. The company focuses on improving patient outcomes and reducing healthcare costs through innovative products and digital health technologies.
Average Trading Volume: 1,136,324
Technical Sentiment Signal: Buy
Current Market Cap: A$54.9B
See more insights into RMD stock on TipRanks’ Stock Analysis page.